135 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
. The benefit from income taxes in the fourth quarter and the year of 2023 was primarily due to a pre-tax loss and our ability to carry back the R&D credit … to 2022. The benefit from income taxes in the fourth quarter of 2022 was primarily due to the Company’s pre-tax loss. The swing from a provision
S-3ASR
EX-1.2
VIR
Vir Biotechnology Inc
3 Nov 23
Automatic shelf registration
4:33pm
.
(t) Tax Law Compliance. The Company and its subsidiaries have paid all federal, state, local and foreign taxes and filed all tax returns required … . Except as otherwise disclosed in the Registration Statement and the Prospectus, there is no tax deficiency that has been asserted against the Company
S-3ASR
EX-4.5
n6xrsx bg6o
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
h595w10 hu59
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.7
71eyia9t1ljz
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.6
8p3n pqo35fl7x
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.8
ow738t
3 Nov 23
Automatic shelf registration
4:33pm
8-K
EX-99.1
5pt2hlgml0bg1u5a55u
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
EX-99.1
f19klu6v7 rjbe
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
hu2hyplx9uv
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm